CVS Health

CVS Health Inc’s (NYSE:CVS) subsidiary, Aetna Inc., has filed a lawsuit against more than 20 generic drug manufacturers. The lawsuit alleges a coordinated scheme to fix prices, allocate markets, and stifle competition. The result was a significant overcharge for essential medications....

Insider buying can be an encouraging signal for potential investors, especially when markets are near all-time highs. Some insiders were picking shares last week in the wake of earnings beats. One oil exploration and production CEO returned to the buy window during the week too. Conventional...

Insider buying can be an encouraging signal for potential investors, especially when markets face uncertainty. Biotech stocks and secondary and initial public offerings were well represented this week. A couple of chief executive officers also stepped up to the buy window last week. Conventional...

Benzinga has examined the prospects for many investor favorite stocks over the past week. This past week's bullish calls included an e-commerce colossus and some surprises. An aerospace leader and a supermarket operator were among last week's bearish calls. As the third-quarter winds...

This weekend's Barron's suggests ways to play U.S.-China tensions and the stock-splitting trend. Other featured articles look at how the election could affect health care stocks and what to expect from big-box retail earnings. Also, the prospects for a pharmaceutical giant, regional bank...

Benzinga has examined the prospects for many investor favorite stocks over the past week. This week's bullish calls included a social media leader and specialty retailers. Big tech stocks and a COVID-19 play were among the week's bearish calls. In another roller-coaster week for the...

This weekend's Barron's cover story offers a look at a company set to shake up health care. Other featured articles examine prospects for oil drillers as takeover targets and for dividend growth stocks. Also, a recent health care spin-off and the newest livestreaming titan. "Can CVS...

Benzinga has featured looks at many investor favorite stocks over the past week. Bullish calls included a top automaker and a leading airline. Bearish calls included a troubled utility and a video game giant. When the big U.S. banks kicked off the fourth-quarter earnings season last week, their...

This weekend's Barron's cover story shows how to find yields of up to 10 percent in the year ahead. Other featured articles examine the prospects for the iPhone maker after last week's debacle and for S&P 500 bargains. Also, a cheap aircraft-leasing company, a truck maker turns...

This weekend's Barron's cover story takes a look tech's next act. Other featured articles reveal how 2018 IPOs fared and look at further headwinds for tech stocks. Also, how to find bargains in European and health care stocks. "Silicon Valley Roundtable on the Outlook for Venture...

This weekend's Barron's offers a look at potential consequences to a proposed restructuring of the S&P sectors. Other featured articles discuss an undervalued master limited partnership and a leading retailer looking to get out from under Amazon's shadow. Prospects for a...

This weekend's Barron's cover story examines why a leading footwear giant is now struggling. Other featured articles discuss a cheaper way to play a Chinese e-commerce giant, what may be the best deals in private equity, and an entertainment giant that has fallen behind. Five top dividend plays...

The Dow Jones Industrial Average hitting 20,000 was no fluke, according to the latest Barron's cover story, as current stock prices are well supported by corporate earnings and economic growth. Unless the new administration stumbles into a trade war, the Dow could overtake the 30,000...

This weekend's Barron's takes a look at the expected winners and losers following Donald Trump's election victory. The prospects for a leading biotechnology product development company and a prominent financial services company are also examined. Other featured stories offer...